Burleson & Company, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Burleson & Company, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$20,0000.0%4580.0%0.00%
+33.3%
Q1 2022$20,0000.0%4580.0%0.00%0.0%
Q4 2021$20,000
+11.1%
4580.0%0.00%0.0%
Q3 2021$18,0000.0%4580.0%0.00%0.0%
Q2 2021$18,000
+12.5%
4580.0%0.00%0.0%
Q1 2021$16,0004580.00%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2023
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,282,289$46,483,4037.25%
Columbia Asset Management 9,960$3610.08%
PARK CIRCLE Co 800$29,0000.03%
PARADIGM ASSET MANAGEMENT CO LLC 1,800$65,2500.02%
Byrne Asset Management LLC 56$2,0000.00%
Retirement Group, LLC 40$1,4500.00%
Bartlett & Co. LLC 240$90.00%
HUNTINGTON NATIONAL BANK 1$400.00%
View complete list of GLAXOSMITHKLINE PLC shareholders